{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T09:17:57Z","timestamp":1783588677419,"version":"3.55.0"},"reference-count":53,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Italian Ministry of Health","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Cutaneous melanoma is an aggressive skin cancer. While laser therapy is established for non-melanoma skin cancers, its role in melanoma remains controversial and largely unsupported by robust clinical evidence. The gold standard for melanoma management remains surgical excision, as it allows for definitive histopathological diagnosis, Breslow thickness measurement, and surgical margin assessment, which are essential for accurate staging. This narrative review analyzed preclinical and clinical studies evaluating various laser modalities, including Nd:YAG, CO2, pulsed dye, photodynamic therapy (PDT) and photothermal therapy (PTT), for efficacy, recurrence rates, and limitations in cutaneous melanoma management. Nd:YAG laser (1064 nm) showed potential for local control in thin stage I melanomas, reporting a low local recurrence rate of 0\u20130.7% and favorable 5-year survival in small, non-randomized cohorts. CO2 laser (10,600 nm) provides effective palliation and local control for in-transit or unresectable metastases, but local recurrence is highly variable, reaching up to 46.7%. Photodynamic therapy showed variable efficacy, although Chlorin e6 achieved complete local regression in a small series of metastases. A critical limitation of laser therapy is the irreversible destruction of tissue, which precludes these vital assessments. Therefore, laser treatment should be cautiously reserved for cases where standard surgery is not feasible, acknowledging that it may interfere with the evaluation of curative outcomes and accurate staging. Laser therapy is a valuable minimally invasive adjunct for local control in selected patients who are poor surgical candidates or require palliative care. Routine use is restricted by the lack of randomized controlled trials. Future studies should prioritize combination strategies with systemic or immunotherapeutic approaches to enhance overall outcomes.<\/jats:p>","DOI":"10.3390\/cancers18101672","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T13:53:24Z","timestamp":1779371604000},"page":"1672","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Role of Laser Modalities in Melanoma Management: Critical Analysis of Local Control and Palliative Applications"],"prefix":"10.3390","volume":"18","author":[{"given":"Francesco","family":"Russano","sequence":"first","affiliation":[{"name":"Soft-Tissue, Peritoneum and Melanoma Surgical Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, 35128 Padua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1564-2594","authenticated-orcid":false,"given":"Luigi","family":"Dall\u2019Olmo","sequence":"additional","affiliation":[{"name":"Soft-Tissue, Peritoneum and Melanoma Surgical Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, 35128 Padua, Italy"},{"name":"Department of Surgery, Oncology and Gastroenterology (DISCOG), University of Padua, 35128 Padua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9594-5178","authenticated-orcid":false,"given":"Francesco","family":"Callegarin","sequence":"additional","affiliation":[{"name":"Clinical Research Unit, Veneto Institute of Oncology IOV\u2014IRCCS, 35131 Padua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9709-977X","authenticated-orcid":false,"given":"Davide","family":"Brugnolo","sequence":"additional","affiliation":[{"name":"Department of Surgery, Oncology and Gastroenterology (DISCOG), University of Padua, 35128 Padua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2862-8014","authenticated-orcid":false,"given":"Paolo","family":"Del Fiore","sequence":"additional","affiliation":[{"name":"Soft-Tissue, Peritoneum and Melanoma Surgical Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, 35128 Padua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Sciacca","sequence":"additional","affiliation":[{"name":"Department of Surgery, Oncology and Gastroenterology (DISCOG), University of Padua, 35128 Padua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocco","family":"Caminiti","sequence":"additional","affiliation":[{"name":"Casa di Cura Caminiti, 89018 Villa San Giovanni, Reggio Calabria, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Rastrelli","sequence":"additional","affiliation":[{"name":"Soft-Tissue, Peritoneum and Melanoma Surgical Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, 35128 Padua, Italy"},{"name":"Department of Surgery, Oncology and Gastroenterology (DISCOG), University of Padua, 35128 Padua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9433-8445","authenticated-orcid":false,"given":"Simone","family":"Mocellin","sequence":"additional","affiliation":[{"name":"Soft-Tissue, Peritoneum and Melanoma Surgical Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, 35128 Padua, Italy"},{"name":"Department of Surgery, Oncology and Gastroenterology (DISCOG), University of Padua, 35128 Padua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,5,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s00403-024-03107-9","article-title":"The palliative role of lasers in the treatment of melanoma","volume":"316","author":"Algarin","year":"2024","journal-title":"Arch. Dermatol. Res."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0140-6736(23)00821-8","article-title":"Cutaneous melanoma","volume":"402","author":"Long","year":"2023","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Saginala, K., Barsouk, A., Aluru, J.S., Rawla, P., and Barsouk, A. (2021). Epidemiology of Melanoma. Med. Sci., 9.","DOI":"10.3390\/medsci9040063"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1001\/jamadermatol.2022.0160","article-title":"Global Burden of Cutaneous Melanoma in 2020 and Projections to 2040","volume":"158","author":"Arnold","year":"2022","journal-title":"JAMA Dermatol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.jid.2016.01.035","article-title":"The Growing Burden of Invasive Melanoma: Projections of Incidence Rates and Numbers of New Cases in Six Susceptible Populations through 2031","volume":"136","author":"Whiteman","year":"2016","journal-title":"J. Investig. Dermatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1080\/15384047.2019.1640032","article-title":"Current state of melanoma diagnosis and treatment","volume":"20","author":"Davis","year":"2019","journal-title":"Cancer Biol. Ther."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/187493a0","article-title":"Stimulated Optical Radiation in Ruby","volume":"187","author":"Maiman","year":"1960","journal-title":"Nature"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1093\/neuonc\/noac208","article-title":"Laser hyperthermia: Past, present, and future","volume":"24","author":"Schupper","year":"2022","journal-title":"Neuro-Oncology"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s40257-020-00562-8","article-title":"Laser Treatment for Non-Melanoma Skin Cancer: A Systematic Review and Meta-Analysis","volume":"22","author":"Sharon","year":"2021","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s11845-025-03942-3","article-title":"A comprehensive study of laser use in dermatology: Assessing the safety, innovations, and effectiveness of laser technology for skin treatment","volume":"194","author":"Diwan","year":"2025","journal-title":"Ir. J. Med. Sci."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Zhang, H., Shi, Y., Ying, J., Chen, Y., Guo, R., Zhao, X., Jia, L., Xiong, J., and Jiang, F. (2023). A bibliometric and visualized research on global trends of immune checkpoint inhibitors related complications in melanoma, 2011\u20132021. Front. Endocrinol., 14.","DOI":"10.3389\/fendo.2023.1164692"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/lsm.10118","article-title":"In vitro study examining the effect of sub-lethal QS 755 nm lasers on the expression of p16INK4a on melanoma cell lines","volume":"32","author":"Chan","year":"2003","journal-title":"Lasers Surg. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1159\/000246133","article-title":"Ex vivo Quality-Switched Ruby Laser Irradiation of Cutaneous Melanocytic Lesions: Persistence of S-100-, HMB-45- and Masson-Positive Cells","volume":"194","author":"Kopera","year":"2009","journal-title":"Dermatology"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1002\/1097-0142(196410)17:10<1299::AID-CNCR2820171012>3.0.CO;2-A","article-title":"The biological effect of laser energy on human melanoma","volume":"17","author":"Helsper","year":"1964","journal-title":"Cancer"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1001\/jama.1966.03100050101035","article-title":"Laser radiation for metastatic malignant melanoma","volume":"195","author":"McGuff","year":"1966","journal-title":"JAMA"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1097\/DSS.0000000000001048","article-title":"An Analysis of Laser Therapy for the Treatment of Nonmelanoma Skin Cancer","volume":"43","author":"Soleymani","year":"2017","journal-title":"Dermatol. Surg."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e15966","DOI":"10.1111\/dth.15966","article-title":"Melanoma surgery\u2014An update","volume":"35","author":"Wollina","year":"2022","journal-title":"Dermatol. Ther."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/1346-8138.17086","article-title":"Current surgical management for melanoma","volume":"51","author":"Koizumi","year":"2024","journal-title":"J. Dermatol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0304-3835(00)00508-5","article-title":"Photothermic treatment of pigmented B16 melanoma using a broadband pulsed light delivery system","volume":"157","author":"Kostenich","year":"2000","journal-title":"Cancer Lett."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1002\/1097-0142(19801115)46:10<2172::AID-CNCR2820461013>3.0.CO;2-L","article-title":"Pulsed laser radiation therapy of skin tumors","volume":"46","author":"Kozlov","year":"1980","journal-title":"Cancer"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3109\/02841867509132682","article-title":"Laser therapy of human benign and malignant neoplasms of the skin","volume":"14","author":"Wagner","year":"1975","journal-title":"Acta Radiol. Ther. Phys. Biol."},{"key":"ref_22","first-page":"3907671","article-title":"Desmoplastic Melanoma Arising after 1,064 nm q-Switched Nd:YAG Laser of a Suspected Solar Lentigo","volume":"2019","author":"Cohen","year":"2019","journal-title":"Case Rep. Dermatol. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1080\/14764172.2017.1349321","article-title":"The use of lasers in the treatment of skin cancer: A review","volume":"19","author":"Mirza","year":"2017","journal-title":"J. Cosmet. Laser Ther."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/lsm.1900050205","article-title":"Treatment of benign, semimalignant, and malignant skin tumors with the Nd:YAG laser","volume":"5","author":"Brunner","year":"1985","journal-title":"Lasers Surg. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1117\/12.250679","article-title":"Treatment of skin melanoma with pulsed radiation from a neodymium laser","volume":"1","author":"Moskalik","year":"1996","journal-title":"J. Biomed. Opt."},{"key":"ref_26","first-page":"389","article-title":"High-energy neodymium laser radiation for the treatment of face cutaneous melanoma","volume":"15","author":"Moskalik","year":"2010","journal-title":"J. BUON"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1007\/s10103-025-04750-y","article-title":"Nd:YAG laser in the treatment of non-melanoma and melanoma skin cancers","volume":"40","author":"Moussa","year":"2025","journal-title":"Lasers Med. Sci."},{"key":"ref_28","first-page":"173","article-title":"Treatment of cutaneous metastases from malignant melanoma using the carbon-dioxide laser","volume":"19","author":"Hill","year":"1993","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/bjs.1800830425","article-title":"Use of the carbon dioxide laser to manage cutaneous metastases from malignant melanoma","volume":"83","author":"Hill","year":"1996","journal-title":"Br. J. Surg."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/bjs.1800780433","article-title":"Carbon dioxide laser ablation of cutaneous metastases from malignant melanoma","volume":"78","author":"Waters","year":"1991","journal-title":"Br. J. Surg."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3109\/14764172.2011.649761","article-title":"Improving the quality of life in melanoma\u2014The role of the CO2 laser","volume":"14","author":"Chan","year":"2012","journal-title":"J. Cosmet. Laser Ther."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/bjs.4558","article-title":"Ten-year experience of carbon dioxide laser ablation as treatment for cutaneous recurrence of malignant melanoma","volume":"91","author":"Gibson","year":"2004","journal-title":"Br. J. Surg."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s10103-008-0580-0","article-title":"Carbon dioxide laser ablation as first-line management of in-transit cutaneous malignant melanoma metastases","volume":"24","author":"Kandamany","year":"2009","journal-title":"Lasers Med. Sci."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1002\/bjs.1800821016","article-title":"Carbon dioxide laser ablation as an alternative treatment for cutaneous metastases from malignant melanoma","volume":"82","author":"Lingam","year":"1995","journal-title":"Br. J. Surg."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/DSS.0000000000000251","article-title":"CO2 laser treatment for regional cutaneous malignant melanoma metastases","volume":"41","author":"Wessels","year":"2015","journal-title":"Dermatol. Surg."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"MMT14","DOI":"10.2217\/mmt-2018-0008","article-title":"Application of CO2 laser evaporation in locally advanced melanoma","volume":"6","author":"Vrielink","year":"2019","journal-title":"Melanoma Manag."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0748-7983(97)93726-4","article-title":"Carbon dioxide laser for cutaneous melanoma metastases: Indications and limitations","volume":"23","author":"Strobbe","year":"1997","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.3892\/ol.2016.5530","article-title":"Dinitrophenyl hapten with laser immunotherapy for advanced malignant melanoma: A clinical study","volume":"13","author":"Chen","year":"2017","journal-title":"Oncol. Lett."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.1016\/j.jaad.2009.12.028","article-title":"The use of pulsed dye laser in the treatment of melanoma metastatic to the skin: A Mayo Clinic case series","volume":"62","author":"Kottschade","year":"2010","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.1365-2133.2005.06307.x","article-title":"Treatment of cutaneous metastatic melanoma with imiquimod 5% cream and the pulsed-dye laser","volume":"152","author":"Zeitouni","year":"2005","journal-title":"Br. J. Dermatol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.4161\/cbt.10.11.13434","article-title":"Clinical effects of in situ photoimmunotherapy on late-stage melanoma patients: A preliminary study","volume":"10","author":"Li","year":"2010","journal-title":"Cancer Biol. Ther."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1111\/j.1365-2133.2006.07514.x","article-title":"In situ photoimmunotherapy: A tumour-directed treatment for melanoma","volume":"155","author":"Naylor","year":"2006","journal-title":"Br. J. Dermatol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.bbmt.2019.03.004","article-title":"Clearance of Hematologic Malignancies by Allogeneic Cytokine-Induced Killer Cell or Donor Lymphocyte Infusions","volume":"25","author":"Merker","year":"2019","journal-title":"Biol. Blood Marrow Transplant."},{"key":"ref_44","first-page":"2628","article-title":"Photoradiation therapy for the treatment of malignant tumors","volume":"38","author":"Dougherty","year":"1978","journal-title":"Cancer Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1001\/archsurg.1989.01410020081013","article-title":"Photodynamic therapy for cutaneous and subcutaneous malignant neoplasms","volume":"124","author":"McCaughan","year":"1989","journal-title":"Arch. Surg."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/1523-1747.ep12479341","article-title":"Photoradiation therapy for cutaneous and subcutaneous malignancies","volume":"77","author":"Dougherty","year":"1981","journal-title":"J. Investig. Dermatol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S1011-1344(96)07376-9","article-title":"Experiences of photodynamic therapy in dermatology","volume":"36","author":"Koderhold","year":"1996","journal-title":"J. Photochem. Photobiol. B Biol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0190-9622(93)70002-B","article-title":"Topical photodynamic therapy with endogenous porphyrins after application of 5-aminolevulinic acid. An alternative treatment modality for solar keratoses, superficial squamous cell carcinomas, and basal cell carcinomas?","volume":"28","author":"Wolf","year":"1993","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1600-0781.2004.00078.x","article-title":"Photodynamic therapy with chlorin e6 for skin metastases of melanoma","volume":"20","author":"Sheleg","year":"2004","journal-title":"Photodermatol. Photoimmunol. Photomed."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S1572-1000(05)00005-0","article-title":"Treatment of melanoma lesions using methylene blue and RL50 light source","volume":"1","author":"Tardivo","year":"2004","journal-title":"Photodiagn. Photodyn. Ther."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s12943-023-01854-3","article-title":"Skin cancer: Understanding the journey of transformation from conventional to advanced treatment approaches","volume":"22","author":"Hasan","year":"2023","journal-title":"Mol. Cancer"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"124952","DOI":"10.1016\/j.ijpharm.2024.124952","article-title":"Combination of gold nanoparticles with near-infrared light as an alternative approach for melanoma management","volume":"668","author":"Lopes","year":"2025","journal-title":"Int. J. Pharm."},{"key":"ref_53","first-page":"24","article-title":"A comparative study of plasmonic nanoparticles for targeted photothermal therapy of melanoma tumors using various irradiation modes","volume":"6","author":"Mikhailova","year":"2025","journal-title":"Light Adv. Manuf."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/10\/1672\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T09:00:20Z","timestamp":1783587620000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/10\/1672"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,21]]},"references-count":53,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["cancers18101672"],"URL":"https:\/\/doi.org\/10.3390\/cancers18101672","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,21]]}}}